A28626
APC Mouse anti-Human CD192/CCR2 monoclonal antibody

Größe
Auf Anfrage
- SKU:
- A28626
- Zusätzliche Namen:
- CC-CKR-2|CCR-2|CCR2A|CCR2B|CD192|CKR2|CKR2A|CKR2B|CMKBR2|MCP-1-R
- Anwendung:
- Flow Cytometry
- Spezies-Reaktivität:
- Human
- Aufreinigung:
- Affinity Purified
- Lagerbedingungen:
- 2-8[o]C Avoid freeze/thaw cycles.
- Hersteller:
- Abclonal
- Host:
- Mouse
- Reaktivitäten:
- Human
- Immunogen:
- Recombinant protein (or fragment).This information is considered to be commercially sensitive.
- Formulierung:
- Unmodified
- Uniprot:
- P41597
- Synonyme:
- C-C chemokine receptor type 2;CC-CKR-2;CCR-2;CCR2A;CCR2B;CD192;chemokine (C-C motif) receptor 2;CKR2;CKR2A;CKR2B;CMKBR2;MCP-1 receptor;MCP-1-R;monocyte chemoattractant protein 1 receptor;monocyte chemotactic protein 1 receptor
- Weitere Details:
- CCR2 is a chemokine receptor that binds monocyte chemoattractant proteins (MCP-1, -2, -3, and -4). Two alternatively spliced variants (CCR2A and CCR2B) were initially described, which differ in their C-terminal cytoplasmic tails. The adhesion of monocytes to arterial endothelium and their subsequent migration into the intima are central events in the pathogenesis of atherosclerosis. Both CCR2 and MCP-1 are implicated in atherosclerotic plaque formation. MCP-1, induced in endothelial cells by modified low-density lipoprotein (LDL), may trigger firm monocyte attachment to the vascular endothelium under flow conditions. Local overexpression of MCP-1 within the vessel wall induces macrophage infiltration and the development of atherosclerotic lesions. Obesity induces a state of chronic inflammation, which is associated with numerous clinically significant complications, including insulin resistance, diabetes mellitus, atherosclerosis, and non-alcoholic fatty liver disease. CCR2 plays a critical role in the development of obesity and the associated inflammation within adipose tissue.
- Versandbedingungen:
- Blue Ice

K1D_FC_01.jpg)